Multidrug resistance (mdr) genes in human cancer

British Journal of Cancer

Volumn 63, Issue 5, 1991, Pages 663-669

  Nooter, K ^a   Herweijer, H ^b  

^a TNO   (Netherlands)

^b Integraal Kankercentrum Rotterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CALCIUM ANTAGONIST; COLCHICINE; CYCLOSPORIN A; DAUNORUBICIN; DEXAMETHASONE; DILTIAZEM; DIPYRIDAMOLE; DOXORUBICIN; NICARDIPINE; NILUDIPINE; PHENOTHIAZINE DERIVATIVE; RESERPINE; TAMOXIFEN; TRIFLUOPERAZINE; TRIPARANOL; VERAPAMIL; VINCA ALKALOID; VINCRISTINE;

CANCER; DRUG RESISTANCE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; DRUG RESISTANCE; GENE EXPRESSION; HUMAN; MEMBRANE GLYCOPROTEINS; NEOPLASMS; P-GLYCOPROTEIN; PHENOTYPE; SUPPORT, NON-U.S. GOV'T;

EID: 0025828251     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1991.152     Document Type: Review

References (104)

1. AKIYAMA, S., CORNWELL, M. M., KUWANO, M., PASTAN, I. & GOTTESMAN, M. M. (1988). Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog. Mol. Pharmacol., 33, 144
2. ARONOW, B., WATTS, T., LASSETTER, L, WASHTIEN, W. & ULLMAN, B. (1984). Biochemical phenotype of 5-fluorouracil-resistant murine T lymphoblasts with genetically altered CTP synthetase activity. J. Biol. Chem., 259, 9033
3. BECH-HANSEN, N. T., TILL, J. E. & LING, V. (1976). Pleiotropic pheno type of colchicine-resistant CHO cells: cross-resistance and col lateral sensitivity. J. Cell Physiol., 88, 23
4. BECK, W. T., CIRTAIN, M. C., GLOVER, C. J., FELSTED, R. L. & SAFA, A. R. (1978)Effects of indole alkaloids on multidrugs resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine. Biochem. Biophys. Res. Comm., 153, 959
5. BEDFORD, P. & FOX, B. W. (1982). Repair of DNA interstrand crosslinks after busulphan. A possible mode of resistance. Cancer Chemother. Pharmacol., 8, 3
6. BELL, D. R., GERLACH, J. H., KARTNER, N., BUICK, R. N. & LING, V. (1985). Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J. Clin. Oncol., 3, 311
7. BOURHIS, J., BÉRNARD, J., HARTMANN, O., BOCCON-GIBOD, L., LEMERLE, J. & RIOU, G. (1989a). Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J. Natl Cancer Inst., 81, 1401
8. BOURHIS, J., GOLDSTEIN, L. J., RIOU, G., PASTAN, L, GOTTESMAN, M. M. & BÉNARD, J. (1989b). Expression of a human multidrug resistance gene in ovarian carcinomas. Cancer Res., 49, 5062
9. BRADLEY, G., JURANKA, P. F. & LING, V. (1988). Mechanism of multidrug resistance. Biochim. Biophys. Acta., 948, 87
10. BRIGHT, J. M. & BUSS, D. D. (1990). Effects of verapamil on chronic doxorubicin-induced cardiotoxicity in dogs. J Natl Cancer Inst., 82, 963
11. CABRAL, F., SOBEL, M. E. & GOTTESMAN, M. M. (1980). CHO mutants resistant to colchicine, colcemid or griseofuluin have an altered betatubulin. Cell, 20, 29
12. CAIRO, M S., SIEGEL, S., ANAS, N. & SENDER, L. (1989). Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP-16 in drug-resistant pediatric tumors. Cancer Res., 49, 1063
13. CALLEN, D. F., BAKER, E., SIMMERS, R. N., SESHADRI, R. & RONIN- SON, I. B. (1987). Localization of the human multiple drug resistance gene, MDR1 to 7q21. 1. Hum. Genet., 77, 142
14. CHAN, H. S. L., THORNER, P. S., HADDAD, G. & LING, V. (1990). Immunohistochemical detection of P-glycoprotein: prognostic cor relation in soft tissue sarcoma of childhood. J. Clin. Oncol., 8, 689
15. CHEN, C., CHIN, J. E., UEDA, K. & 4 others (1986). Internal duplication and homology with bacterial transport proteins in the mdr 1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell, 47, 381
16. CHIN, J.E., SOFFIR, R., NOONAN, K.E, CHOI, K.&RONINSON, I.B. (1986)Structure and expression of the human MDR (P-glyco protein) gene family. Mol. Cell. Biol., 9, 3808
17. CHIN, K. V., TANAKA, S., DARLINGTON, G., PASTAN, I. & GOTTES MAN, M. M. (1990). Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem., 265, 221
18. CORDON-CARDO, C., O’BRIEN, J. P., BOCCIA, J., CASALS, D., BERTINO, J. R. & MELAMED, M. R. (1990). Expression of the multidrug resis tance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem., 38, 1277
19. CORNWELL, M. M., PASTAN, I. & GOTTESMAN, M. M. (1987). Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J. Biol. Chem., 262, 2166
20. DALTON, W. S., GROGAN, T. M., MELTZER, P. S. & 5 others (1989a). Drug-resistance in multiple myeloma and non-Hodgkin’s lym phoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J. Clin. Oncol., 7, 415
21. DALTON, W. S., GROGAN, T. M., RYBSKI, J. A. & 6 others (1989b). Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulation. Blood, 73, 747
22. DAN0, K. (1972). Cross-resistance between Vinca alkaloids and anthra cyclines in Ehrlich ascites tumor in vivo. Cancer Chemother. Rep., 56, 701
23. DAN0, K. (1973). Active outward transport of daunomycine in resistant Ehrlich ascites tumor cells. Biochim. Biophys. Acta., 323, 466
24. EPSTEIN, J., XIAO, H. & OBA, B. K. (1989). P-glycoprotein expression in plasma-cell myeloma is associated with resistance to VAD. Blood, 74, 913
25. FEDELI, L., COLOZZA, M., BOSCHETTI, E. & 8 others (1989). Pharmaco kinetics of vincristine in cancer patients treated with nifedipine. Cancer, 64, 1805
26. FIGUEREDO, A., ARNOLD, A., GOODYEAR, M. & 4 others (1990). Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer. A phase I/II study. Cancer, 65, 1895
27. FLINTOFF, W. F. & ESSANI, K. (1980). Methotrexate resistance Chinese hamster ovary cells contain a dihydrofolate reductase with an altered affinity for methotrexate. Biochemistry, 19, 4321
28. FOJO, A T., SHEN, D., MICKLEY, L. A., PASTAN, I. & GOTTESMAN, M. M. (1987a). Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene. J. Clin. Oncol., 5, 1922
29. FOJO, A. T., UEDA, K., SLAMON, D. J., POPLACK, D. G., GOTTESMAN, M. M. & PASTAN, I. (1987b). Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl Acad. Sci. USA, 84, 265
30. FORD, J. M., PROZIALECK, W. C. & HAIT, W. N. (1989). Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance. Mol. Pharmacol., 35, 105
31. FOXWELL, B. M. J., MACKIE, A., LING, V. & RYFFEL, B. (1989). Identi fication of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein. Mol. Pharmacol., 36, 543
32. GALSKI, H., SULLIVAN, M., WILLINGHAM, M. C. & 4 others (1989). Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: resistance to daunomycin-induced leukopenia. Mol. Cell. Biol., 9, 4357
33. GERLACH, J. H., BELL, D. R., KARAKOUSIS, C. & 5 others (1987). P-glycoprotein in human sarcoma: evidence for multidrug resis tance. J. Clin. Oncol., 5, 1452
34. GERLACH, J. H., ENDICOTT, J. A., JURANKA, P. F. & 4 others (1986). Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug-resistance. Nature, 324, 485
35. GOLDSTEIN, L. J., FOJO, A T., UEDA, K. & 5 others (1990). Expression of the multidrug resistance, MDR1, gene in neuroblastomas. J. Clin. Oncol., 8, 128
36. GOLDSTEIN, L. J., GALSKI, H., FOJO, A. T. & 11 others (1989). Expres sion of a multidrug resistance gene in human cancers. J. Natl Cancer Inst., 81, 116
37. GROS, P., CROOP, J. & HOUSMAN, D. (1986). Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homo logy to bacterial transport proteins. Cell, 47, 371
38. GROS, P., RAYMOND, M., BELL, J. & HOUSMAN, D. (1988). Cloning and characterization of a second member of the mouse mdr gene family. Mol. Cell. Biol., 8, 2770
39. HAM ADA, H. & TSURUO, T. (1986). Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl Acad. Sci. USA, 83, 7785
40. HAMADA, H. & TSURUO, T. (1988). Characterization of the ATPase activity of the Mr 170, 000 to 180, 000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res., 48, 4926
41. HERWEIJER, H., SONNEVELD, P., BAAS, F. & NOOTER, K. (1990). Expression of mdrl and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J. Natl Cancer Inst., 82, 1133
42. HOFSLI, E. & NISSEN-MEYER, J. (1990). Reversal of multidrug resis tance by lipophilic drugs. Cancer Res., 50, 3997
43. HOLMES, J., JACOBS, A., CARTER, G., JANOWSKA-WIECZOREK, A. & PADUA, R. A. (1989). Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia. Br. J. Haematol., 72, 40
44. HOLMES, J. A., JACOBS, A., CARTER, G., WHITTAKER, J. A., BENTLEY, D. P. & PADUA, R. A. (1990). Is the mdrl gene relevant in chronic lymphocytic leukemia? Leukemia, 4, 216
45. HORIO, M., GOTTESMAN, M. M. & PASTAN, I. (1988). ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc. Natl Acad. Sci. USA, 85, 3580
46. INABA, M. & JOHNSON, R. K. (1977). Decreased retention of actino- mycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia. Cancer Res., 37, 4629
47. JONES, R. D., KERR, D. J., HARNETT, A N., RANKIN, E. M., RAY, S. & KAYE, S. B. (1990). A pilot study of quinidine and epirubicin in the treatment of advanced breast cancer. Br. J. Cancer, 62, 133
48. KAKEHI, Y., KANAMARU, H., YOSHIDA, O.&4others(1988).Measurementfmultidrug-resistance messenger RNA in urogenital cancers; elevated expression in renal cell carcinoma is associated with intrinsic drug resistance. J. Urol., 139, 862
49. KANAMARU, H., KAKEHI, Y., YOSHIDA, O., NAKANISHI, S., PASTAN, I. & GOTTESMAN, M. M. (1989). MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants. J. Natl Cancer Inst., 81, 844
50. KARTNER, N., EVERNDEN-PORELLE, D., BRADLEY, G. & LING, V. (1985). Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature, 316, 820
51. KEITH, W. N., STALLARD, S. & BROWN, R. (1990). Expression of mdrl and gst-n in human breast tumours: comparison to in vitro chemosensitivity. Br. J. Cancer, 61, 712
52. KERR, D. J., GRAHAM, J., CUMMINGS, J. & 4 others (1986). The effect of verapamil on the pharmacokinetics of adriamycin. Cancer Chemo- ther. Pharmacol., 18, 239
53. KESSEL, D. & BOSMANN, H. B. (1970). On the characteristics of actinomycin D resistance in L5178Y cells. Cancer Res., 30, 2695
54. KESSEL, D. & WILBERDING, C. (1985). Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists. Cancer Res., 45, 1687
55. KOHNO, K., SATO, S., TAKANO, H., MATSUO, K. & KUWANO, M. (1989). The direct activation of human multidrug resistance gene (mdrl) by anticancer agents. Biochem. Biophys. Res. Common., 165, 1415
56. KRISHAN, A., SAUERTEIG, A., GORDON, K. & SWINKIN, C. (1986). Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells. Cancer Res., 46, 1768
57. LAI, S., GOLDSTEIN, L. J., GOTTESMAN, M. M. & 7 others (1989). MDR1 gene expression in lung cancer. J. Natl Cancer Inst., 81, 1144
58. MA, D. D. F., DAVEY, R. A., HARMAN, D. H. & 5 others (1987). Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia. Lancet, 1, 135
59. MILLER, R. L., BUKOWSKI, R. M., BUDD, G. T. & 5 others (1988). Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/III trial. J. Clin. Oncol., 6, 880
60. MOSCOW, J. A. & COWAN, K. H. (1990). Multidrug resistance. In Cancer Chemotherapy and Biological Response Modifiers Annual 11, Pinedo, H. M., Chabner, B. A. & Longo, D. L. (eds) p. 97. Elsevier Science Publishers: Amsterdam
61. MOSCOW, J. A., FAIRCHILD, C. R., MADDEN, M. J. & 7 others (1989). Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res., 49, 1422
62. NAITO, M. & TSURUO, T. (1989). Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement. Cancer Res., 49, 1452
63. NG, W. F., SARANGI, F., ZASTAWNY, R. L., VEINOT-DREBOT, L. & LING, V. (1989). Identification of members of the P-glycoprotein multigene family. Mol. Cell. Biol., 9, 1224
64. NOGAE, I., KOHNO, K., KIKUCHI, J. & 8 others (1989). Analysis of structural features of dihydropyridine analogs needed to reverse multidrug resistance and to inhibit photoaffinity labeling of P- glycoprotein. Biochem. Pharmacol., 38, 519
65. NOOTER, K., OOSTRUM, R. & DEURLOO, J. (1987). Effects of verapamil on the pharmacokinetics of daunomycin in the rat. Cancer Chemo- ther. Pharmacol., 20, 176
66. NOOTER, K., OOSTRUM, R., JONKER, R., VAN DEKKEN, H., STOKDIJK, W. & van den ENGH, G. (1989). Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry. Cancer Chemother. Pharmacol., 23, 296
67. NOOTER, K., SONNEVELD, P., JANSSEN, A. & 6 others (1990a). Expression of the mdr3 gene in prolymphocytic leukemia: associa tion with cyclosporin-A-induced increase in drug-accumulation. Int. J. Cancer, 45, 626
68. NOOTER, K., SONNEVELD, P., OOSTRUM, R., HERWEIJER, H., HAGENBEEK, A. & VALERIO, D. (1990b). Overexpression of the mdrl gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin-A. Int. J. Cancer, 45, 263
69. OZOLS, R. F., CUNNION, R. E., KLECKER, R. W. & 4 others (1987). Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients. J. Clin. Oncol., 5, 641
70. PEARCE, H. L., SAFA, A. R., BACH, N. J., WINTER, M. A., CIRTAIN, M. C. & BECK, W. T. (1989). Essential features of the P-glycoprotein pharma cophore as defined by a series of reserpine analogs that modulate multidrug resistance. Proc. Natl Acad. Sci. USA, 86, 5128
71. PIRKER, R., GOLDSTEIN, L. J., LUDWIG, H. & 4 others (1989). Expres sion of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia. Cancer Common., 1, 141
72. RAMU, A., GLAUBIGER, D. & FUKS, Z. (1984). Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxi fen and other triparanol analogues. Cancer Res., 44, 4392
73. RAMU, N. & RAMU, A. (1989). Circumvention of adriamycin resistance by dipyridamole analogues: a structure-activity relationship study. Int. J. Cancer, 43, 487
74. REDWOOD, W. R. & COLVIN, M. (1980). Transport of melphalan by sensitive and resistant L1210 cells. Cancer Res., 40, 1144
75. RIEHM, H. & BIEDLER, J. L. (1972). Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin. Cancer Res., 32, 1195
76. RONINSON, I. B., CHIN, J. E., CHOI, K. & 6 others (1986). Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinomas cells. Proc. Natl Acad. Sci. USA, 83, 4538
77. ROTHENBERG, M L., MICKLEY, L. A., COLE, D. E. & 4 others (1989). Expression of the mdrl/P-170 gene in patients with acute lympho blastic leukemia. Blood, 74, 1388
78. SAFA, A. R. (1988). Photoaffinity labeling of the multidrug-resistance- related P-glycoprotein with photoactive analogs of verapamil. Proc. Natl Acad. Sci. USA, 85, 7187
79. SALMON, S. E., GROGAN, T. M., MILLER, T., SCHEPER, R. & DALTON, W. S. (1989). Prediction of doxorubicin resistance in vitro in mye loma, lymphoma, and breast cancer by P-glycoprotein staining. J. Natl Cancer Inst., 81, 696
80. SATO, H., GOTTESMAN, M. M., GOLDSTEIN, L. J. & 4 others (1990). Expression of the multidrug resistance gene in myeloid leukemias. Leukemia Res., 14, 11
81. SCHNEIDER, J., BAK, M., EFFERTH, T., KAUFMANN, M., MATTERN, J. & VOLM, M. (1989). P-glycoprotein expression in treated and untreated human breast cancer. Br. J. Cancer, 60, 815
82. SIROTNAK, F. M., MOCCIO, D. M., KELLEHER, L. E. & GOUTAS, L. J. (1981). Relative frequency and kinetic properties of transport- defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo. Cancer Res., 41,. 4447
83. SIROTNAK, F. M., YANG, C., MINES, L. S., ORIBE, E. & BIEDLER, J. L. (1986). Markedly altered membrane transport and intracellular binding of vincristine in multidrug-resistant Chinese hamster cells selected in resistance to vinca alkaloids. J. Cell. Physiol., 126, 266
84. SKOVSGAARD, T. (1978). Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells. Cancer Res., 38, 4722
85. SLATER, L. M., SWEET, P., STUPECKY, M. & GUPTA, S. (1986). Cyclo sporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro. J. Clin. Invest., 77, 1405
86. SONNEVELD, P. & NOOTER, K. (1990). Reversal of drug-resistance by cyclosporin-A in a patient with acute myelocytic leukaemia. Br. J. Haematol., 75, 208
87. THIEBAUT, F., TSURUO, T., HAMADA, H., GOTTESMAN, M. M., PAS TAN, I. & WILLINGHAM, M. C. (1987). Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl Acad. Sci. USA, 84, 7735
88. TSURUO, T., IIDA, H., KITATANI, Y., YOKOTA, K., TSUKAGOSHI, S. & SAKURAI, Y. (1984). Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. Cancer Res., 44, 4303
89. TSURUO, T., IIDA, H., TSUKAGOSHI, S. & SAKURAI, Y. (1981). Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res., 41, 1967
90. TSURUO, T., IIDA, H., TSUKAGOHSI, S. & SAKURAI, Y. (1982). Increased accumulation of vincristine and adriamycin in drug- resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res., 42, 4730
91. TSURUO, T., KAWABATA, H., NAGUMO, N. &4 others (1985). Potentia tion of antitumour agents by calcium channel blockers with special references to cross-resistance patterns. Cancer Chemother. Pharma col., 15, 16
92. TSURUO, T., SUGIMOTO, Y., HAMADA, H. & 5 others (1987). Detection of multidrug resistance markers, P-glycoprotein and mdr1 mRNA, in human leukemia cells. Jpn. J. Cancer Res. (Gann), 78, 1415
93. TWENTYMAN, P. R. (1988). Modification of cytotoxic drug resistance by non-immunosuppressive cyclosporins. Br. J. Cancer, 57, 254
94. UEDA, K., CARDARELLI, C., GOTTESMAN, M. M. & PASTAN, I. (1987). Expression of a full-length cDNA for the human 'MDR1' gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl Acad. Sci. USA, 84, 3004
95. VAN DER BLIEK, A. M., BAAS, F., TEN HOUTE-DE LANGE, T., KOOIMAN, P. M., VAN DER VELDE-KOERTS, T. & BORST, P. (1987). The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver. EMBO J., 6, 3325
96. VAN DER BLIEK, A M., BAAS, F., VAN DER VELDE-KOERTS, T. & 6 Others (1988b). Genes amplified and overexpressed in human multidrug- resistant cell lines. Cancer Res., 48, 5927
97. Van der BLIEK, A. M. & BORST, P. (1989). Multidrug-Resistance. In Advances in Cancer Research 52, van de Woude, G. F. & Klein, G. (eds) p. 165. Academic Press: New York
98. VAN DER BLIEK, A. M., KOOIMAN, P. M., SCHNEIDER, C. & BORST, P. (1988a). Sequence of mdr3 cDNA encoding a human P-glyco- protein. Gene, 71, 401
99. VANDERVALK, P., VANKALKEN, C. K., KETELAARS, H. &8Others (1988).Distribution of multidrug resistance-associated P-glyco- protein in normal and neoplastic human tissues. Ann. Oncol., 1, 56
100. VERWEIJ, J., HERWEIJER, H., PLANTING, A. S. T. & 4 others (1990). In vitro and in vivo studies on the effect of cyclosporin-A (Cy-A) in the circumvention of clinical multidrug resistance (MDR). Proc. Am. Soc. Clin. Oncol., 9, 74
101. WEINSTEIN, R. S., KUSZAK, J. R., KLUSKENS, L. F. & COON, J. S. (1990). P-glycoproteins in pathology - the multidrug resistance gene family in humans. Hum. Pathol., 21, 34
102. WILLINGHAM, M. C., CORNWELL, M. M., CARDARELLI, C. O., GOTTESMAN, M. M. & PASTAN, I. (1986). Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effect of verapamil and other drugs. Cancer Res., 46, 5941
103. YALOWICH, J. C. & ROSS, W. E. (1985). Verapamil-induced augmenta tion of etoposide accumulation in LI210 cells in vitro. Cancer Res., 45, 1651
104. ZAMORA, J. M., PEARCE, H. L. & BECK, W. T. (1988). Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol. Pharmacol., 33, 454